PACIFIC 5-Yr Update
PACIFIC: 5-Year Survival Outcomes With Consolidation Durvalumab vs Placebo After Concurrent CRT in Unresectable Stage III NSCLC

Released: June 06, 2021

Activity

Progress
1
Course Completed